Persistent high GRPR affinity and specificity were validated using in vivo blocking studies, with a significant reduction in tumor uptake of both 68Ga-labeled monomeric and dimeric TMs when pre-dosed with Ava-BBN2. This evidence concerns the gene GRPR and neoplasm.